Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do neuroleptics cause depression?

A Roy

    Biological Psychiatry
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This study found that antipsychotic medications, like chlorpromazine, do not seem to cause depression in patients with schizophrenia. Researchers matched depressed and non-depressed schizophrenia patients to compare medication dosages.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Further evidence for low serum cholesterol and suicidal behaviour.

    Journal of affective disorders·2000
    Same author

    Relation of family history of suicide to suicide attempts in alcoholics.

    The American journal of psychiatry·2000
    Same author

    [Autoimmune hepatitis in children. Initial presentation as fulminant hepatic failure].

    Acta gastroenterologica Latinoamericana·2000
    Same author

    Malnutrition and hypernatraemia in breastfed babies.

    Annals of tropical paediatrics·2000
    Same author

    Somatosensory evoked potentials associated with thermal activation of type II Adelta mechanoheat nociceptive afferents.

    The International journal of neuroscience·2000
    Same author

    Coronary artery bypass grafting without cardiopulmonary bypass in pheochromocytoma.

    The Journal of thoracic and cardiovascular surgery·2000
    Same journal

    Neuroimaging of Heterogeneity in Neuropsychiatric Disorders: Toward Disease Progression Modeling.

    Biological psychiatry·2026
    Same journal

    Impact of Transcranial Direct Current Stimulation-Induced Electric Fields on Slowing Cognitive Decline in Older Adults With Mild Cognitive Impairment or Remitted Major Depressive Disorder: An Analysis of the PACt-MD Randomized Clinical Trial.

    Biological psychiatry·2026
    Same journal

    Remembering Jon-Kar Zubieta, M.D., Ph.D.

    Biological psychiatry·2026
    Same journal

    Kappa opioid receptor availability in borderline personality disorder: An in-vivo investigation with [<sup>11</sup>C]EKAP PET imaging.

    Biological psychiatry·2026
    Same journal

    From Satiety to Substance Use: Neural Mechanisms of GLP-1 Signaling in Appetite and Reward.

    Biological psychiatry·2026
    Same journal

    Distinct and Shared Molecular Mechanisms Underlie Morphological-Functional Overcoupling and Undercoupling in Major Depressive Disorder.

    Biological psychiatry·2026
    See all related articles

    Area of Science:

    • Psychiatry
    • Clinical Psychology

    Background:

    • Depression is a common comorbidity in schizophrenia.
    • The etiology of depression in schizophrenia remains unclear.
    • Antipsychotic medications are a potential factor.

    Purpose of the Study:

    • To investigate if antipsychotic medication dosage contributes to depression in schizophrenia patients.
    • To differentiate between endogenous depression and medication-induced depression in this population.

    Main Methods:

    • Matched case-control study design.
    • 18 chronic schizophrenic outpatients with major depressive episodes were compared to 18 matched non-depressed schizophrenic outpatients.
    • Mean equivalent daily dosage of chlorpromazine was compared between groups.

    Related Experiment Videos

    Main Results:

    • No significant difference in the mean equivalent daily dosage of chlorpromazine was found between the depressed and non-depressed schizophrenic groups.
    • This suggests that neuroleptic medication dosage is not a significant factor in the development of depressive episodes in this cohort.

    Conclusions:

    • Antipsychotic medications, specifically chlorpromazine, do not appear to induce depressive disorder in chronic schizophrenic patients.
    • The findings suggest that depression in schizophrenia likely stems from other etiological factors.
    • Further research is needed to explore other potential causes of depression in schizophrenia.